Skip to Content

Long-term remission found with combination therapy for young patients with CLL

A 2.5-year time-limited regimen with combination treatment of ibrutinib and FCR shows potential to generate long-term remission for a group of young patients with chronic lymphocytic leukemia.

ASH21 poster hall

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top